Z. Al-Khazragie, M. Sabri, L. Sabri, and H. Al-Atbi, “Integrated in silico and in vitro profiling of newly designed heterocyclic thiazolidinone targeting androgen-independent prostate cancer”, Babcock Univ. Med. J., vol. 9, no. 3, pp. 151–162, Sep. 2026.